The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with our audited consolidated financial
statements and related notes in Item 8 of this Annual Report on Form 10-K. Item
7 in this Form 10-K discusses our fiscal 2022 and fiscal 2021 results and the
year-over-year comparisons between fiscal 2022 and fiscal 2021. Discussion of
our fiscal 2021 results and the year-over-year comparisons between fiscal 2021
and fiscal 2020 can be found in "Management's Discussion and Analysis of
Financial Condition and Results of Operations" in Part II, Item 7 of our Annual
Report on Form 10-K for the year ended January 2, 2022, filed with the SEC on
March 10, 2022, and incorporated by reference in this Form 10-K. In addition to
historical financial information, the following discussion contains
forward-looking statements that reflect our current expectations, estimates and
assumptions concerning events and financial trends that may affect our future
operating results or financial position. Actual results and the timing of events
may differ materially from those discussed or implied in our forward-looking
statements due to a number of factors, including those described in the sections
entitled "Risk Factors" and "Special Note Regarding Forward-Looking Statements"
and elsewhere herein.

Our fiscal year ends on the Sunday closest to the end of the twelfth calendar
month. We refer to the fiscal years ended January 1, 2023 and January 2, 2022 as
fiscal 2022 and fiscal 2021, respectively. Fiscal years 2022 and 2021 each
include 52 weeks. All percentage amounts and ratios presented in this
management's discussion and analysis were calculated using the underlying data
in thousands. Unless otherwise indicated, all changes identified for the current
period results represent comparisons to results for the prior corresponding
period.

For purposes of this section, the terms "we," "us," "our," "CMI Acquisition" and
"SkyWater" refer to CMI Acquisition, LLC and its subsidiaries collectively
before the corporate conversion discussed below and to SkyWater Technology, Inc.
and its subsidiaries collectively after the corporate conversion.

Corporate Conversion and Initial Public Offering



On April 14, 2021, in connection with the IPO of our common stock, CMI
Acquisition, LLC filed a certificate of conversion, whereby CMI Acquisition, LLC
effected a corporate conversion from a Delaware limited liability company to a
Delaware corporation and changed its name to SkyWater Technology, Inc., which we
refer to as the corporate conversion. As part of the corporate conversion,
holders of Class B preferred units and common units of CMI Acquisition, LLC
received shares of our common stock for each unit held immediately prior to the
corporate conversion using an approximate one-to-1.56 conversion ratio for Class
B preferred units and one-to-1.45 conversion ratio for common units.

On April 23, 2021, we completed our IPO and issued 8,004,000 shares of common
stock, including the underwriter's exercise of their right to purchase
additional shares, at an initial offering price to the public of $14.00 per
share. Shares of our common stock began trading on the Nasdaq Stock Market on
April 21, 2021 under the symbol "SKYT".

We received net proceeds from the IPO of approximately $100.2 million, after
deducting underwriting discounts and commissions and offering costs of
approximately $11.9 million. We utilized approximately $45 million of our IPO
proceeds to pay down our revolving credit agreement, approximately $28 million
of our IPO proceeds to fund capital expenditures, and approximately $27 million
of our IPO proceeds to fund our operating activities.

Overview



We are a U.S.-based, independent, pure-play technology foundry that offers
advanced semiconductor development and manufacturing services from our
fabrication facility, or fab, in Minnesota and advanced packaging services from
our Florida facility. In our technology-as-a-service model, we leverage a strong
foundation of proprietary technology to co-develop process technology IP with
our customers that enables disruptive concepts through our Advanced Technology
Services for diverse microelectronics (ICs) and related micro- and
nanotechnology applications. In addition to differentiated technology
development services, we support customers with volume production of ICs for
high-growth markets through our Wafer Services.

The combination of semiconductor development and manufacturing services we
provide our customers is not available to them from a conventional fab. In
addition, our status as a publicly-traded, U.S.-based pure-play technology
foundry with DMEA Category 1A Trusted Accreditation from the DoD, positions us
well to provide distinct, competitive advantages to our customers. These
advantages include the benefits of enhanced IP security and easy access to a
U.S. domestic supply chain.

We primarily focus on serving diversified, high-growth, end users in numerous
vertical markets, including (1) advanced computation, (2) A&D, (3) automotive
and transportation, (4) bio-health, (5) consumer and (6) industrial/ IoT. By
housing both development and manufacturing in a single operation, we rapidly and
efficiently transition newly-developed processes to high-yielding volume
production, eliminating the time it would otherwise take to transfer
                                       38
--------------------------------------------------------------------------------

production to a third-party fab. Through our Advanced Technology Services, we
specialize in co-creating with our customers advanced solutions that directly
serve our end markets, such as superconducting ICs for quantum computing,
integrated photonics, CNTs, MEMS, technologies for biomedical and imaging
applications, and advanced packaging. Our Wafer Services include the manufacture
of silicon-based analog and mixed-signal ICs for our end markets. Our focus on
the differentiated analog and CMOS markets supports long product life-cycles and
requirements that value performance over cost-efficiencies, and leverages our
portfolio IP.

Before we began independent operations, our fab was owned and operated by
Cypress as a captive manufacturing facility for 26 years. We have leveraged the
Cypress system, manufacturing technology and process development capabilities to
advance our product offerings. We became an independent company in March 2017
when we were acquired by Oxbow, as part of a divestiture from Cypress. Our
multi-year foundry services agreement with Cypress, which ended in June 2020,
created a runway for us to operate the foundry at a high utilization rate while
continuing to expand and diversify the customer base transferred by Cypress.
Cypress was acquired in April 2020 by Infineon Technologies AG, or Infineon.

Factors and Trends Affecting our Business and Results of Operations



The following trends and uncertainties either affected our financial performance
in fiscal 2022 and fiscal 2021, or are reasonably likely to impact our results
in the future.

•Macroeconomic and competitive conditions, including cyclicality and consolidation, as well as the global availability of significant incentives in semiconductor technology and manufacturing, affecting the semiconductor industry.



•The global economic climate, including the impact on the economy from
geopolitical issues and the ongoing COVID-19 pandemic. Because we have a
manufacturing facility, we may be vulnerable to an outbreak of a new coronavirus
or other contagious diseases. The effects of such an outbreak could include the
temporary shutdown of our facilities, disruptions or restrictions on the ability
to ship our products to our customers, as well as disruptions that may affect
our suppliers. Any disruption of our ability to manufacture or distribute our
products or of the ability of our suppliers to delivery key components on a
timely basis could have material adverse effect on our revenue and operating
results. See "Risk Factors-The ongoing COVID-19 pandemic has adversely affected
and could continue to adversely affect our business, results of operations and
financial condition." and our consolidated financial statements for further
information regarding the effects of the COVID-19 pandemic on our business.

•On August 9, 2022, President Biden signed into law the Creating Helpful
Incentives to Produce Semiconductors, or CHIPS, and Science Act, in which the
United States has committed to a renewed focus on providing incentives and
funding for onshore companies to develop and advance the latest semiconductor
technologies, supporting onshore manufacturing capabilities, and on
strengthening key onshore supply chains. The act authorizes the U.S. Department
of Commerce to enable execution of CHIPS awards and provides $52.7 billion for
American semiconductor research, development, manufacturing, and workforce
development, including $39 billion in financial assistance to build, expand, or
modernize domestic facilities and equipment for semiconductor fabrication,
assembly, testing, advanced packaging, or research and development.

•Our overall level of indebtedness from our revolving credit agreement for up to
$100 million, which we refer to as the Revolver, and a $37 million financing
from the sale of the land and building representing our headquarters in
Minnesota, which we refer to as the Financing, the corresponding interest rates
charged to us by our lenders and our ability to access borrowings under the
Revolver.

•Identification and pursuit of specific product and geographic market opportunities that we find attractive both within and outside the United States. We will continue to more effectively address these opportunities through research and development and allocation of additional revenue and marketing resources.



•Material and other cost inflation. We strive for productivity improvements, and
we implement increases in selling prices to help mitigate inflation. We expect
the current economic environment will result in continuing price volatility and
inflation for many of our raw materials. In addition, the labor market for
skilled manufacturing remains tight and our labor costs have increased as a
result.

•Supply chain disruptions impacting our business. We have experienced, and may
continue to experience, supply chain disruption for substrates, chemicals and
spare parts in addition to customer supply chain constraints that have
negatively impacted our revenue.

Financial Performance Metrics

Our senior management team regularly reviews certain key financial performance metrics within our business, including:

•revenue and gross profit; and



•earnings before interest, taxes, depreciation and amortization, as adjusted, or
adjusted EBITDA, which is a financial measure not prepared in accordance with
accounting principles generally accepted in the United States, or U.S. GAAP,
that excludes certain items that may not be indicative of our core operating
results, as well as items that can vary widely across different industries or
among companies within the same industry. For information regarding our non-GAAP
financial measure, see the section entitled "-Non-GAAP Financial Measure" below.
                                       39
--------------------------------------------------------------------------------

Results of Operations

This section contains an analysis of our results of operations presented in the accompanying consolidated statement of operations.

Fiscal 2022 Compared to Fiscal 2021



The following table summarizes certain financial information relating to our
operating results for the fiscal years ended January 1, 2023 and January 2,
2022.

                                                     Year Ended
                                           January 1,           January 2,            Dollar                Percentage
                                            2023 (1)             2022 (1)             Change                  Change

                                                                           (in thousands)
Consolidated Statement of Operations
Data:
Revenue                                  $   212,941          $   162,848          $   50,093                          31  %
Cost of revenue:
Cost of revenue, before inventory
write-down                                   186,974              156,878              30,096                          19  %
Inventory write-down (Note 17)                     -               13,442             (13,442)                       (100) %
Total cost of revenue                        186,974              170,320              16,654                          10  %
Gross profit (loss)                           25,967               (7,472)             33,439                             nm
Research and development                       9,431                8,747                 684                           8  %
Selling, general and administrative
expenses                                      46,303               43,595               2,708                           6  %
Change in fair value of contingent
consideration                                      -               (2,710)              2,710                        (100) %
Operating loss                               (29,767)             (57,104)             27,337                         (48) %
Other income (expense):
Paycheck Protection Program loan
forgiveness                                        -                6,453              (6,453)                       (100) %
Loss on debt extinguishment                   (1,101)                   -              (1,101)                            nm
Interest expense                              (5,194)              (3,542)             (1,652)                         47  %
Total other income (expense)                  (6,295)               2,911              (9,206)                        316  %
Loss before income taxes                     (36,062)             (54,193)             18,131                          33  %
Income tax expense (benefit)                     809               (6,790)              7,599                             nm
Net loss                                     (36,871)             (47,403)             10,532                          22  %
Less: net income attributable to
non-controlling interests                      2,722                3,293                (571)                         17  %
Net loss attributable to SkyWater
Technology, Inc.                         $   (39,593)         $   (50,696)         $   11,103                          22  %
Other Financial Data:
Adjusted EBITDA (2)                      $     7,717          $    (2,629)         $   10,346                             nm


nm - Not meaningful
______________________

(1)The consolidated statements of operations are for fiscal 2022 and fiscal 2021. Our fiscal year ends on the Sunday closest to the end of the calendar year. Fiscal 2022 and fiscal 2021 each contained 52 weeks. (2)See "-Non-GAAP Financial Measure" for the definition of adjusted EBITDA and reconciliation to the most directly comparable GAAP measure.

Revenue

Revenue increased $50.1 million, or 31%, to $212.9 million for fiscal 2022, from $162.8 million for fiscal 2021. The increase for fiscal 2022 was driven by continued momentum in revenue for both our Wafer Services and Advanced Technology Services, primarily in the aerospace and defense industry.

The following table shows revenue by services type for fiscal 2022 and fiscal 2021:


                                       40
--------------------------------------------------------------------------------


                                                       Year Ended                            Dollar                Percentage
                                        January 1, 2023           January 2, 2022            Change                  Change

                                                                             (in thousands)
Wafer Services                        $         73,495          $         51,157          $   22,338                          44  %
Advanced Technology Services                   139,446                   111,691              27,755                          25  %
Total                                 $        212,941          $        162,848          $   50,093                          31  %


Wafer Services revenue increased $22.3 million, or 44%, year-over-year, from
$51.2 million in fiscal 2021 to $73.5 million in fiscal 2022. The increase was
primarily driven by a $13.3 million contract modification with one of our
primary customers. During the first quarter of fiscal 2022, we signed a new
contract with an existing customer that included increased pricing terms and
modified other terms, whereby revenue is recognized over time. As a result, we
recognized additional non-recurring revenue of $8.3 million in the first quarter
of fiscal 2022 to account for recognition of wafer services activities in
process at the date the contract was signed, and an additional $5.0 million over
the remainder of 2022.

Advanced Technology Services revenue increased $27.8 million, or 25%, year-over
year, from $111.7 million in fiscal 2021 to $139.4 million in fiscal 2022. The
increase was driven by continued program expansion with existing customers and
new program additions. Additionally, in fiscal 2022 and fiscal 2021, Advanced
Technology Services revenue included revenue of $1.5 million and $19.2 million,
respectively, related to services we provide to qualify customer funded tool
technologies as our customers invest in our capabilities to expand our
technology platforms. In the fourth quarter of fiscal 2022, we had a significant
contract modification with a customer pursuant to which the customer's option to
purchase discounted services expired, resulting in a recognition of $4.7 million
of revenue previously recorded as a contract liability. During the third and
fourth quarter of fiscal 2021, our Advanced Technology Services experienced
supply chain challenges, hiring constraints, and continued delays in the funding
of existing United States government programs. This resulted in delayed revenue
for certain Advanced Technology Services and Wafer Services programs in the
amount of approximately $15 million for the third and fourth quarter of fiscal
2021. This included a revised schedule for a significant complex multi-year
Advanced Technology Services program originally estimated to be completed in
2021 to early 2022, causing revenue to be pushed from 2021 into 2022.

Gross profit (loss)



Gross profit (loss) increased $33.4 million, to $26.0 million for fiscal 2022,
from $(7.5) million for fiscal 2021. The increase was due to increased top line
revenue outpacing the increase in Cost of revenue as our Advanced Technology
Services and Wafer Services functions continued to mature and gain efficiencies.
The increase in Cost of revenue was primarily due increased labor costs, which
increased $13.6 million year-over-year as we continued to hire at our Minnesota
and Florida facilities to support increased activities. Year-over-year, our full
time labor population increased 16%. We experienced wage inflation due to an
increasingly competitive labor market in 2022, similar to others in the
semiconductor industry, as well as the labor market in general. In addition,
direct spend increased by $15.8 million year-over-year primarily due to
increases in customer costs related to the RH90 program, utility rates, and
equipment maintenance costs.

Inventory Write-down



In the fourth quarter of fiscal 2021, we recorded a full inventory write-down of
$13.4 million to cost of revenue for inventory which we were contracted to
manufacture for a customer. The customer's financing for its COVID-19-related
business was not obtained and the customer was unable to meet it contractual
payment obligations. We have filed a claim against the customer for full
payment. We explored alternative sales channels, such as partnering with a
customer, to sell the inventory. However, our sales efforts have not progressed
and it is not probable we will recover the value of the inventory.

Research and development



Research and development costs increased to $9.4 million for fiscal 2022, from
$8.7 million for fiscal 2021. The increase of $0.7 million, or 8%, was
attributable to increased personnel expense of $0.9 million and increased
software expense of $0.7 million, partially offset by decreased equity-based
compensation expense of $0.7 million.

Selling, general and administrative expenses



Selling, general and administrative expenses increased to $46.3 million for
fiscal 2022, from $43.6 million for fiscal 2021. The increase of $2.7 million,
or 6%, was attributable to increased personnel expense of $1.4 million, as well
as an increase in direct expenses, including increases in insurance expense of
$1.5 million; government relations expense of $0.5 million; technology-related
expenses of $0.8 million; and other direct expenses of $1.4 million. These
increases were partially offset by a decrease in equity-based compensation
expense of $2.9 million.

Change in fair value of contingent consideration

Change in fair value of contingent consideration was $0.0 for fiscal 2022, compared to a decrease of $2.7 million for fiscal 2021. The contingent consideration is based on estimated royalties owed on Advanced Technology Services revenues, with respect to which we paid a quarterly royalty through 2022. In connection with our acquisition of the


                                       41
--------------------------------------------------------------------------------

business from Cypress, we recorded a contingent consideration liability for the
future estimated earn-out/royalties owed on Advanced Technology Services
revenues. For each reporting period thereafter, we revalued future estimated
earn-out payments and record the changes in fair value of the liability in our
consolidated statements of operations.

Loss on debt extinguishment



In fiscal 2022, we expensed $1.1 million of unamortized debt issuance costs and
fees in connection with the extinguishment of debt in December 2022. There was
no loss on debt extinguishment in 2021.

Interest expense



Interest expense increased to $5.2 million for fiscal 2022, from $3.5 million
for fiscal 2021. The increase of $1.7 million, or 47%, was due to increases in
both the average outstanding balance and the average interest rate for the
Revolver from 2021 to 2022.

Income tax expense (benefit)



Income tax expense increased to $0.8 million for fiscal 2022 from a benefit of
$6.8 million for fiscal 2021. The effective income tax rate was (2.2)% for
fiscal 2022 compared to 12.5% for fiscal 2021. The effective income tax rate was
lower for fiscal 2022 and fiscal 2021 than our statutory tax rate of 21%
primarily due to a deferred tax asset valuation allowance. The income tax
benefit for fiscal 2021 included the tax impact from the gain on the PPP Loan
forgiveness, which is exempt from federal income taxation. Refer to Note 7 -
Income Taxes in the notes to our consolidated financial statements for further
discussion of income taxes.

Net income attributable to non-controlling interests



Net income attributable to non-controlling interests decreased to $2.7 million
for fiscal 2022 from $3.3 million for fiscal 2021. Net income attributable to
non-controlling interests reflects the net income of the variable interest
entity, or VIE, that we consolidate, representing the economic interest in the
profits and losses of Oxbow Realty that the owners of our shareholders' equity
do not legally have rights or obligations to.

Adjusted EBITDA



Adjusted EBITDA increased $10.3 million, to $7.7 million for fiscal 2022 from
$(2.6) million for fiscal 2021. The increase in adjusted EBITDA primarily
reflects increased gross profit as top line revenue in both Advanced Technology
Services and Wafer Services revenue continues to grow, while cost of revenue
stays relatively stable. For a discussion of adjusted EBITDA as well as a
reconciliation to the most directly comparable U.S. GAAP measure, see "-Non-GAAP
Financial Measure."

Liquidity and Capital Resources

General



Our ability to execute our operating strategy is dependent on our ability to
maintain liquidity and continue to access capital through our Revolver and other
sources of financing. Our current business plans indicate that we may require
additional liquidity to continue our operations for the next 12 months from the
issuance of the consolidated financial statements. We have identified specific
actions we could take to reduce operating costs to improve cash flow, which
include a reduction in spending and a delayed increase in certain personnel, and
may require us to decrease our level of investment in new products and
technologies, or discontinue further expansion of our business. We also obtained
a support letter from Oxbow Industries, LLC, an affiliate of our principal
stockholder, to provide funding in an amount up to $12.5 million, if necessary,
to enable us to meet our obligations as they become due through at least one
year beyond the issuance of the consolidated financial statements. Management
believes that based upon the Company's operational forecasts, cash and cash
equivalents on hand, available borrowings on our Revolver, potential cost
reduction measures and the support letter from an affiliate of our principal
stockholder, as needed, will provide sufficient liquidity to fund its operations
for the next 12 months from the issuance of the consolidated financial
statements.

Additionally, we could raise additional capital through the ATM Program (as defined below) and seek additional equity or debt financing, including a refinancing and/or expansion of the Revolver; however we cannot provide any assurance that additional funds will be available when needed from any source or, if available, will be available on terms that are acceptable to us.



The Company has based this estimate on assumptions that may prove to be wrong,
and its operating plan may change as a result of many factors currently unknown
to it. To the extent that our current resources and plans to reduce expenses are
insufficient to satisfy our cash requirements, we may need to seek additional
equity or debt financing. Our ability to do so depends on prevailing economic
conditions and other factors, many of which are beyond our control.

We had $30.0 million in cash and cash equivalents, not including cash held by a variable interest entity that we consolidate, and availability under our Revolver of $22.0 million as of January 1, 2023. We are subject to certain liquidity and EBITDA covenants under our Loan Agreement, as outlined in the Indebtedness section of Item 7. Management's Discussion and Analysis below.


                                       42
--------------------------------------------------------------------------------

Initial Public Offering



We received net proceeds from the IPO of approximately $100.2 million in fiscal
2021, after deducting underwriting discounts and commissions and offering costs
of approximately $11.9 million. Refer to "Corporate Conversion and Initial
Public Offering" earlier in this section for further information on our Initial
Public Offering.

Open Market Sale Agreement

On September 2, 2022, the Company entered into an Open Market Sale Agreement
with Jefferies LLC with respect to an at the market offering program under which
the Company may, from time to time, offer and sell up to $100 million in shares
of the Company's common stock. From the date of the Open Market Sale Agreement
through January 1, 2023, the Company sold 435,419 shares under the Open Market
Sale Agreement at an average sale price of $9.28 per share, resulting in gross
proceeds of approximately $4.0 million before deducting sales commissions and
fees of approximately $0.6 million. The Company used the net proceeds of
approximately $3.5 million to pay down its Revolver and fund its operations. As
of January 1, 2023, approximately $96 million in shares were available for
issuance under the Open Market Sale Agreement.

Common Stock Offering



On November 17, 2022, we completed a public offering (the "Offering") and issued
1,916,667 shares of common stock, including the underwriter's exercise of its
right to purchase additional shares, at a price per share of $9.00 to the
public, less underwriting discounts and commissions. We received net proceeds of
$16.1 million from the Offering, after deducting the underwriting discounts and
commissions. We used the net proceeds from the Offering primarily for general
corporate purposes, which included, among other things, funding of operations,
repayment of indebtedness, additions to working capital and/or capital
expenditures.

Capital Expenditures



On July 26, 2021, we announced that our board of directors approved $56 million
in strategic capital investments for expanding manufacturing capacity and
technology capabilities at our Minnesota facility. The majority of this
investment is targeted to expand capacity and capabilities at our Minnesota fab
which is expected to increase overall output by at least 40% and to enable
accelerated revenue growth. The remainder is focused on expediting our entry
into the gallium nitride, or GaN market, a promising technology for electric
vehicles, 5G and consumer electronics, among others due to its properties that
enable higher charging efficiencies, smaller ship size, and lighter weight for
many applications. We believe SkyWater can fill the need for a US-based 200 mm
foundry to offer technology services for GaN-based solutions expanding the
serviceable market for our technology-as-a-serviceSM model and we are in the
process of identifying a partner to commercialize this technology. The strategic
capital investment is a multi-year strategy and we invested approximately $11.1
million and $13.8 million during fiscal 2022 and 2021, respectively,
substantially all of which was for expanding capacity and capabilities at our
Minnesota fab.

For fiscal 2022 and 2021, we spent approximately $18.6 million and $32.0
million, respectively, on capital expenditures, including purchases of property,
equipment and software. The majority of these capital expenditures relate to our
foundry expansion in Minnesota, as discussed below, and the development of our
advanced packaging capabilities at the Center for NeoVation in Florida. We
anticipate our cash on hand and the availability under the Revolver will provide
the funds needed to meet our customer demand and anticipated capital
expenditures in fiscal 2023.

We have various contracts outstanding with third parties in connection with
expansion of our manufacturing capabilities at our Minnesota fab and Center for
NeoVation in Florida. We have approximately $4.8 million of contractual
commitments outstanding as of January 1, 2023 that we expect to be paid in
fiscal 2023 through cash on hand and operating cash flows. During 2022, the
Company executed a capital lease to replace the existing nitrogen plant with a
larger and more modern nitrogen generator. The capital lease has a lease term of
15 years for total payments of $14 million.

Contingent Consideration

For fiscal 2022 and 2021, we made cash payments of $0.8 million and $7.4 million, respectively, related to our contingent consideration royalty liability. There are no future cash payments to be made related to this liability, as the amount has been settled.

Working Capital



Historically, we have depended on cash on hand, funds available under our
Revolver and, more recently, net proceeds from sales of our common stock
pursuant to the ATM Program and the Offering, and in the future may depend on
additional debt and equity financings to finance our expansion strategy, working
capital needs and capital expenditures. We believe that these sources of funds
will be adequate to provide cash, as required, to support our strategy, ongoing
operations, capital expenditures, lease obligations and working capital for at
least the next 12 months. However, we cannot be certain that we will be able to
obtain future debt or equity financings adequate for our cash requirements on
commercially reasonable terms or at all.

As of January 1, 2023, we had available aggregate undrawn borrowing capacity of
approximately $22.0 million under our Revolver. For the periods presented, our
use of cash was primarily driven by our operating and investing activities, and
specifically by our investments in capital expenditures.
                                       43
--------------------------------------------------------------------------------

The following table sets forth general information derived from our statement of cash flows for fiscal 2022 and 2021:



                                                           Year Ended
                                             January 1, 2023       January 2, 2022

                                                         (in thousands)
Net cash used in operating activities       $        (14,297)     $        (55,680)
Net cash used in investing activities       $        (17,453)     $        (29,823)
Net cash provided by financing activities   $         48,858      $         90,984


Cash and Cash Equivalents

At January 1, 2023 and January 2, 2022, we had $30.0 million and $12.9 million
of cash and cash equivalents, respectively, including cash of $0.0 million and
$0.5 million held by a variable interest entity that we consolidate.

Operating Activities



Cash flow from operations is driven by changes in the working capital needs
associated with the various goods and services we provide, and expenses related
to the infrastructure in place to support revenue generation. Working capital is
primarily affected by changes in accounts receivable, accounts payable, accrued
expenses, and deferred revenue, all of which tend to be related and are affected
by changes in the timing and volume of work performed. Net cash used in
operating activities was $14.3 million during fiscal 2022, a decrease of $41.4
million from $55.7 million of net cash used in operating activities during
fiscal 2021. The decrease in cash used in operating activities in fiscal 2022
was driven primarily by an increase in accounts payable of $21.0 million in
fiscal 2022 compared to a decrease in accounts payable of $6.5 million in fiscal
2021. Our accounts payable and accrued expenses increased during fiscal 2022 due
to the timing of cash payments to our suppliers and vendors.

Investing Activities



Capital expenditures are a significant use of our capital resources. These
investments are intended to enable sales growth in new and expanding markets,
help us meet product demand and increase our manufacturing efficiencies and
capacity. Net cash used in investing activities was $17.5 million during fiscal
2022, a decrease of $12.3 million from $29.8 million in fiscal 2021. The
decrease in cash used in fiscal 2022 reflects decreased capital spending on
property and equipment as we fully completed our foundry expansion project in
2021 to increase manufacturing capacity at our Minnesota facility and decreased
capital spending on software.

Financing Activities



Net cash provided by financing activities was $48.9 million during fiscal 2022,
a decrease of $42.1 million from net cash provided by financing activities of
$91.0 million during fiscal 2021. The decrease was driven by proceeds of over
$100.0 million from the IPO in fiscal 2021, partially offset by proceeds from
the issuance of common stock and net proceeds from our new revolver in fiscal
2022.

Indebtedness

Sale Leaseback Transactions

On September 29, 2020, we entered into an agreement to sell the land and
building representing our primary operating location in Bloomington, Minnesota
to Oxbow Realty for $39 million, less applicable transaction costs of $1.5
million and transaction services fees paid to Oxbow Realty of $2.0 million, and
paid a guarantee fee to our principal stockholder of $2.0 million. We
subsequently entered into an agreement to lease the land and building from Oxbow
Realty for initial payments of $0.4 million per month over 20 years. The monthly
payments are subject to a 2% increase each year during the term of the lease. We
are also required to make certain customary payments constituting "additional
rent," including certain monthly reserve, insurance and tax payments, in
accordance with the terms of the lease. Due to our continuing involvement in the
property, we are accounting for the transactions as a failed sale leaseback (a
financing transaction). Under failed sale leaseback accounting, we are deemed
the owner of the property with the proceeds received recorded as a financial
obligation.

On October 20, 2022, we entered into an agreement to sell a semiconductor
manufacturing tool to an equipment financing lender for $3.1 million. We
subsequently entered into an agreement to lease the tool from the lender for
monthly payments of $0.1 million over 42 months. The agreement provides for a
bargain purchase option at the end of the lease term, which we intend to
exercise. Because control of the asset did not transfer to the lender, and due
to our intent to exercise the bargain purchase option at the end of the lease
term, we accounted for the transaction as a failed sale leaseback (a financing
transaction). Under failed sale leaseback accounting, we are deemed the owner of
the property with the proceeds received recorded as a financial obligation.
                                       44
--------------------------------------------------------------------------------

Revolving Credit Agreement



On December 28, 2022, we entered into a Loan and Security Agreement (the "Loan
Agreement") with Siena Lending Group LLC ("Siena"). The Loan Agreement provides
for a revolving line of credit of up to $100 million with scheduled maturity
date of December 28, 2025 (the "Revolver"). The Company incurred $4.3 million of
debt issuance costs, which will be amortized as additional interest expense over
the life of the Revolver. In connection with the entry into the Loan Agreement,
the Company drew $60.0 million on the Revolver and repaid $43.5 million in
outstanding indebtedness under, and terminated, our lending agreement with Wells
Fargo and recognized a $1.1 million write-off of unamortized debt issuance
costs. As of January 1, 2023, we had borrowings of $60.1 million under the
Revolver.

Borrowing under the Loan Agreement is limited by a borrowing base of specified
advance rates applicable to billed accounts receivable, unbilled accounts
receivable, inventory and equipment, subject to various conditions, limits and
any availability block as provided in the Loan Agreement. The Loan Agreement
also provides for borrowing base sublimits applicable to each of unbilled
accounts receivable and equipment. Under certain circumstances, Siena may from
time to time establish and revise reserves against the borrowing base and/or the
maximum revolving facility amount.

Borrowings under the Loan Agreement bear interest at a rate that depends upon
the type of borrowing, whether a term secured overnight financing rate (SOFR)
loan or base rate loan, plus the applicable margin. The term SOFR loan rate is a
forward-looking term rate based on SOFR for a tenor of one month on the
applicable day, subject to a minimum of 2.5% per annum. The base rate is the
greatest of the prime rate, the Federal funds rate plus 0.5%, and 7.% per annum.
The applicable margin is an applicable percentage based on the fix charged
coverage ratio that ranges from 6.25% to 5.25% per annum for term SOFR loans and
ranges from 5.25% to 4.25% per annum for base rate loans.

The Loan Agreement contains customary representations and warranties and
financial and other covenants and conditions. Subject to certain cure rights,
the Loan Agreement requires $10 million in minimum EBITDA (as defined in the
Loan Agreement) calculated as of the last day of each calendar month commencing
April 30, 2023 for the preceding twelve calendar months, prohibits unfunded
capital expenditures in excess of $15 million calculated as of the last day of
each calendar month commencing April 30, 2023 for the preceding twelve calendar
months, and requires a minimum fixed charge coverage ratio, measured on a
trailing 12 month basis, of not less than 1.00 to 1.00 if our liquidity is less
than $15 million. In addition, the Loan Agreement places certain restrictions on
our ability to incur additional indebtedness (other than permitted
indebtedness), to create liens or other encumbrances (other than liens relating
to permitted indebtedness), to sell or otherwise dispose of assets, to merge or
consolidate with other entities, and to make certain restricted payments,
including payments of dividends to our stockholders. We were in compliance with
the covenants of the Loan Agreement as of January 1, 2023.

Due to a lockbox clause in the Loan Agreement, the outstanding loan balance is required to be serviced with working capital, and the debt is classified as short-term on the consolidated balance sheet in accordance with Accounting Standards Codification ("ASC") 470-10-45-5.

Material Cash Requirements



Our material cash requirements from known contractual and other obligations
primarily relate to following, for which information on both a short-term and
long-term basis is provided in the indicated notes to the consolidated financial
statements:

•Debt-Refer to Note 6.

•Capital expenditure commitments-Refer to Note 13.

•Capital lease commitments-Refer to Note 16.

•Sale leaseback obligation-Refer to Note 18.

•Tax obligations-Refer to Note 7.

•Other commitments and contingencies-Refer to Note 13.

Recent Accounting Developments

For information on new accounting pronouncements, see Note 3 to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K.

JOBS Act



We qualify as an "emerging growth company" pursuant to the provisions of the
JOBS Act. For as long as we are an "emerging growth company," we may take
advantage of certain exemptions from various reporting requirements that are
applicable to other public companies that are not "emerging growth companies,"
including, but not limited to, not being required to comply with the auditor
attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in our periodic reports
and proxy statements, exemptions from the requirements of holding advisory
"say-on-pay" votes on executive compensation and shareholder advisory votes on
golden parachute compensation.

The JOBS Act also permits an emerging growth company like us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. We have elected to use the


                                       45
--------------------------------------------------------------------------------

extended transition period for complying with new or revised accounting standards and, therefore, we will not be subject to the same new or revised accounting standards as other public companies that comply with such new or revised accounting standards on a non-delayed basis.

Critical Accounting Policies and Estimates



Our consolidated financial statements are prepared in accordance with U.S. GAAP.
In connection with preparing our consolidated financial statements, we are
required to make assumptions and estimates about future events and apply
judgments that affect the reported amounts of assets, liabilities, revenue and
expense, and the related disclosures. We base our assumptions, estimates and
judgments on historical experience, current trends and other factors that
management believes to be relevant at the time we prepare our consolidated
financial statements. On a regular basis, management reviews the accounting
policies, assumptions, estimates and judgments to ensure that our consolidated
financial statements are presented fairly and in accordance with U.S. GAAP.
However, because future events and their effects cannot be determined with
certainty, actual results could differ materially from our assumptions and
estimates.

On an ongoing basis, management evaluates its estimates, including those related
to revenue recognition, valuation of long-lived assets and inventory,
share-based compensation and income taxes. We base our estimates and judgments
on historical experience and on various other factors that we believe to be
reasonable under the circumstances, the results of which form the basis for
making judgments about the carrying values of assets and liabilities that are
not readily apparent from other sources. Actual results may materially differ
from these estimates under different assumptions or conditions.

Revenue Recognition



Revenue is recognized either over time as work progresses using an output
measure or at a point-in-time, depending upon contract-specific terms and the
pattern of transfer of control of the product or service to the customer. Due to
the nature of our contracts, there can be judgement involved in determining the
performance obligations that are included in the related contract. We analyze
each contract to conclude what enforceable rights and obligations exist between
us and our customers. In doing so, we determine our unit of account by
identifying the promises within the contract that are both (1) considered to be
distinct and (2) distinct within the context of each contract

Advanced Technology Services - We have both fixed price and time-and-materials
contracts. The customer receives the benefits provided by our performance as we
complete them, and revenue is recognized from our fixed price and
time-and-materials contracts over time as we perform. Revenue on fixed price
contracts is recognized either over time as work progresses using the input or
output method based upon which method we believe represents the best indication
of the overall progress toward satisfying our performance obligation. Over time
revenue recognition using the output method relies on surveys of performance
completed to date to satisfy our performance obligation. This can require
judgment to determine the related measure of progress that will be assigned to
the respective contract. Over time revenue recognition using the input method,
is based on costs incurred to date on performance obligations compared to
estimated total cost required to complete the performance obligation as of the
reporting date. We measure progress on these performance obligations by
comparing total costs incurred to-date to the total estimated costs for the
performance obligation, and record that proportion of the total performance
obligation transaction price as revenue in the period. Costs include labor,
manufacturing costs, materials and other direct costs related to the customer
contract. During the third quarter of 2022, we signed new contracts with a
significant Advanced Technology Services customer that we are recording revenue
based upon the input method using a cost-based measure of progress. We believe
this method of recognizing revenue is consistent with our progress in satisfying
our contract obligations. The estimation of total costs for the performance
obligation can require significant judgment and any adjustment to estimated
total cost may have an impact on proportion of progress achieved resulting in a
cumulative catch-up of revenue.

Wafer Services - In March 2022, we signed a new contract with a significant
wafer services customer. Under the contract, orders are non-cancellable and we
have an enforceable right to complete the orders and to payment for any finished
or in-process wafers plus a reasonable margin. The wafers produced for that
customer are highly customized and have no alternative use to us. Control of
these wafers is deemed to transfer to the customer over time during the
fabrication process, using the same measure of progress toward satisfying the
promise to deliver the units to the customer. Consequently, the transaction
price is recognized as revenue over time based on actual costs incurred in the
fabrication process to date relative to total expected costs to produce all
wafers beginning in March 2022. The contract terms and pricing is applicable to
all in-process and future wafers. We recorded revenue of $13.3 million for the
twelve months ended January 1, 2023 to account for recognition of Wafer Services
activities. Additionally, this change in the timing of revenue recognition
reduced our work-in-process inventory and increased our unbilled receivables
(contract assets) and cost of revenue.

The terms of a contract and historical business practices can, but generally do
not, give rise to variable consideration. We estimate variable consideration at
the most likely amount we will receive from customers. We include estimated
amounts in the transaction price to the extent it is probable that a significant
reversal of cumulative revenue recognized for such transaction will not occur,
or when the uncertainty associated with the variable consideration is resolved.
In general, variable consideration in our contracts relates to the entire
contract. Our estimates of variable consideration and determination of whether
to include estimated amounts in the transaction price are based largely on an
assessment of our anticipated performance and all information (historical,
current, and forecasted) that is reasonably available to us at contract
inception and require judgment. We have no significant instances where variable
consideration is
                                       46
--------------------------------------------------------------------------------

constrained and not recorded at the initial time of sale. In addition, we have
not experienced significant changes to our estimates and judgments related to
variable consideration in our contracts.

If we make material changes to our assumptions, we may have to make cumulative
catch-up adjustments in the financial statements related to revenue previously
recognized. No material gross favorable or unfavorable changes to our material
long-term contracts existed for fiscal 2022 or fiscal 2021.

Long-lived Assets



We review long-lived assets, including property and equipment and intangible
assets with definite lives, for impairment whenever events or changes in
circumstances, known as triggering events, indicate that the asset's carrying
amount may not be recoverable. Triggering events include, but are not limited
to, reduced or expected sustained decreases in cash flows generated by an asset
or asset group, negative changes in industry conditions, a significant change in
a long-lived asset's use or physical condition and the introduction of competing
technologies. For purposes of impairment testing, we group assets and
liabilities at the lowest level for which identifiable cash flows are largely
independent of the cash flows of other assets and liabilities and evaluate the
asset group against the sum of the undiscounted future cash flows. If the
undiscounted cash flows do not exceed the carrying value of the long-lived asset
or asset group, the asset group is not recoverable and impairment is recognized
to the extent the carrying amount exceeds the estimated fair value of the asset
or asset group. The undiscounted cash flow analysis consists of estimating the
future cash flows that are directly associated with, and are expected to arise
from, the use and eventual disposition of the asset over its remaining useful
life. These estimated discounted cash flows are inherently subjective and
include significant assumptions, specifically the forecasted revenue, forecasted
operating margins, and require estimates based upon historical experience and
future expectations. Due to our history of operating losses and uncertainty with
forecasts, we utilized third party appraisers to assess the estimated fair value
of our long-lived asset group. The estimated fair value of our long-lived assets
exceeded the carrying value. As such, we did not experience an impairment of our
long-lived assets despite having triggering events during fiscal 2022 and fiscal
2021.

Appraisals utilize various approaches to determine fair value, including the
income approach, the sales comparison approach and the cost approach. Each
appraisal approach is inherently subjective and includes significant
assumptions, specifically the comparability of similar properties or equipment,
the potential income and expenses that would be derived or incurred to rent
those long-lived assets, obsolescence factors, and capitalization and discount
rates.

Income Taxes

In determining taxable income for financial statement purposes, we must make
certain estimates and judgments. These estimates and judgments affect the
calculation of certain tax liabilities and the determination of the
recoverability of certain of the deferred tax assets, which arise from temporary
differences between the tax and financial statement recognition of revenue and
expenses. In evaluating our ability to recover our deferred tax assets, we
consider all available positive and negative evidence including our past
operating results, the existence of cumulative losses in the most recent years
and our forecast of future taxable income. In estimating future taxable income,
we develop assumptions regarding the reversal of temporary differences. These
assumptions require significant judgment about the forecasts of future taxable
income and are consistent with the plans and estimates we are using to manage
the underlying business.

We currently have recorded a valuation allowance that we will maintain until, in
the opinion of management, it is more likely than not that some portion or all
of the deferred tax assets will be realized. Our income tax expense recorded in
the future may be reduced to the extent of a decrease in our valuation
allowance. The realization of our remaining deferred tax assets is primarily
dependent on future taxable income. Any reduction in future taxable income may
require that we record an additional valuation allowance against our deferred
tax assets. An increase in the valuation allowance could result in additional
income tax expense in such period and could have a significant impact on our
future earnings. Because the determination of the amount of deferred tax assets
that can be realized is based, in part, on our forecast of future profitability,
it is inherently uncertain and subjective. Changes in market conditions and our
assumptions may cause the actual future profitability to differ materially from
our current expectation, which may require us to increase or decrease the
valuation allowance.

Changes in tax laws and rates could also affect recorded deferred tax assets and
liabilities in the future. Management records the effect of a tax rate or law
change on our deferred tax assets and liabilities in the period of enactment.
Future tax rate or law changes could have a material effect on our financial
condition, results of operations or cash flows.

Non-GAAP Financial Measure



Our audited consolidated financial statements are prepared in accordance with
U.S. GAAP. To supplement our audited consolidated financial statements presented
in accordance with U.S. GAAP, an additional non-GAAP financial measure is
provided and reconciled in the following table.

We provide supplemental non-GAAP financial information that our management
utilizes to evaluate our ongoing financial performance and provide additional
insight to investors as supplemental information to our U.S. GAAP results. We
use adjusted EBITDA to provide a baseline for analyzing trends in our business
and to exclude certain items that may not be indicative of our core operating
results. The use of non-GAAP financial information should not be considered as
an alternative to, or more meaningful than, the comparable U.S. GAAP measure. In
addition, because our non-GAAP measure is not determined in accordance with U.S.
GAAP, it is susceptible to differing calculations, and not all comparable or
peer companies may calculate their non-GAAP measures in the same manner. As a
result, the non-GAAP financial measure
                                       47
--------------------------------------------------------------------------------

presented in this Annual Report on Form 10-K may not be directly comparable to similarly titled measures presented by other companies.

This non-GAAP financial measure should not be considered as an alternative to, or more meaningful than, net income determined in accordance with U.S. GAAP.

Adjusted EBITDA



Adjusted EBITDA is not a financial measure determined in accordance with U.S.
GAAP. We define adjusted EBITDA as net income (loss) before interest expense,
income tax provision (benefit), depreciation and amortization, equity-based
compensation and certain other items that we do not view as indicative of our
ongoing performance, including fair value changes in contingent consideration,
management fees, inventory write-down, corporate conversion and IPO related
costs, Paycheck Protection Program Loan forgiveness, SkyWater Florida start-up
costs, net income attributable to non-controlling interests, and management
transition expense.

We believe adjusted EBITDA is a useful performance measure because it allows for
an effective evaluation of our operating performance when compared to our peers,
without regard to our financing methods or capital structure. We exclude the
items listed above from net income in arriving at adjusted EBITDA because these
amounts can vary substantially within our industry depending upon accounting
methods and book values of assets, capital structures and the method by which
the assets were acquired. Adjusted EBITDA should not be considered as an
alternative to, or more meaningful than, net income determined in accordance
with U.S. GAAP. Certain items excluded from adjusted EBITDA are significant
components in understanding and assessing a company's financial performance,
such as a company's cost of capital and tax structure, as well as the historic
costs of depreciable assets, none of which are reflected in adjusted EBITDA. Our
presentation of adjusted EBITDA should not be construed as an indication that
our results will be unaffected by the items excluded from adjusted EBITDA. In
future fiscal periods, we may exclude such items and may incur income and
expenses similar to these excluded items. Accordingly, the exclusion of these
items and other similar items in our non-GAAP presentation should not be
interpreted as implying that these items are non-recurring, infrequent or
unusual, unless otherwise expressly indicated.

The following table presents a reconciliation of net income (loss) to adjusted
EBITDA, our most directly comparable financial measure calculated and presented
in accordance with U.S. GAAP.

                                                                              Year Ended
                                                                   January 1,            January 2,
                                                                      2023                  2022

Net loss attributable to SkyWater Technology, Inc.               $    (39,593)         $    (50,696)
Interest expense (9)                                                    6,295                 3,542
Income tax (benefit) expense                                              809                (6,790)
Depreciation and amortization                                          28,192                27,368
EBITDA                                                                 (4,297)              (26,576)
Inventory write-down (1)                                                    -                13,442
Paycheck Protection Program loan forgiveness                                -                (6,453)

Corporate conversion and initial public offering related costs (2)

                                                                         -                 1,934
SkyWater Florida start-up costs (3)                                       686                 1,147
Management transition expense (4)                                           -                   435
Fair value changes in contingent consideration (5)                          -                (2,710)
Equity-based compensation (6)                                           8,606                12,527
Management fees (7)                                                         -                   332
Net income attributable to non-controlling interests (8)                2,722                 3,293
Adjusted EBITDA                                                  $      7,717          $     (2,629)


__________________

(1)Represents a full write-down for inventory which we were contracted to manufacture for a specific customer. See Note 17 - Inventory Write Down in the notes to our consolidated financial statements for additional information.



(2)Represents expenses directly associated with the corporate conversion and
IPO, such as professional, consulting, legal and accounting services. This also
includes bonus awards granted to employees upon the completion of the IPO. These
expenses are not indicative of our ongoing costs and were discontinued following
the completion of our initial public offering.

(3)Represents start-up costs associated with our 200 mm advanced packaging
facility in Kissimmee, Florida, which includes legal fees, recruiting expenses,
retention awards and facility start-up expenses. These expenses are not
indicative of our ongoing costs and will be discontinued following completion of
the start-up of SkyWater Florida.
                                       48
--------------------------------------------------------------------------------

(4)Represents expense for the departure of our former Chief Administrative Officer, which includes primarily severance benefits.

(5)Represents non-cash valuation adjustment of contingent consideration to fair market value during the period.

(6)Represents non-cash equity-based compensation expense.



(7)Represents a related party transaction with Oxbow, our principal stockholder.
As these fees are not part of the core business, will not continue after our IPO
and are excluded from management's assessment of the business, we believe it is
useful to investors to view our results excluding these fees.

(8)Represents net income attributable to our VIE, which was formed for the
purpose of purchasing our land and building with the proceeds of a bank loan.
Since depreciation and interest expense are excluded from net loss in our
adjusted EBITDA financial measure, we also exclude the net income attributable
to the VIE.

(9)Includes losses related to the extinguishment of our revolving credit agreement.

© Edgar Online, source Glimpses